Paul McBarron
Overview
Paul McBarron received an average of $550K in total compensation, including $289K in salary, at Cyclacel Pharmaceuticals from 2006 to 2023.
2023Cyclacel PharmaceuticalsExecutive Vice President, Finance, Chief Financial Officer, Chief Operating Officer, Secretary
2022Cyclacel PharmaceuticalsExecutive Vice President, Finance, Chief Financial Officer, Chief Operating Officer, Secretary
2021Cyclacel PharmaceuticalsExecutive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, Secretary
2020Cyclacel PharmaceuticalsExecutive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, Secretary
2019Cyclacel PharmaceuticalsExecutive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, Secretary
2018Cyclacel PharmaceuticalsExecutive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, Secretary
2017Cyclacel PharmaceuticalsExecutive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, Secretary
2016Cyclacel PharmaceuticalsExecutive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, Secretary
2015Cyclacel PharmaceuticalsExecutive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, Secretary
2014Cyclacel PharmaceuticalsExecutive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, Secretary
Related executives
We found eight more executives who work or worked at Cyclacel Pharmaceuticals.
Spiro Rombotis
Cyclacel Pharmaceuticals
Chief Executive Officer
Mark Kirschbaum
Cyclacel Pharmaceuticals
Chief Medical Officer
Judy Chiao
Cyclacel Pharmaceuticals
Vice President, Clinical Development and Regulatory Affairs
Greg Reyes
Cyclacel Pharmaceuticals
Senior Vice President Research
John Womelsdorf
Cyclacel Pharmaceuticals
Vice President, Business Development
Robert Jackson
Cyclacel Pharmaceuticals
Chief Scientific Officer
Robert Kirkman
Cyclacel Pharmaceuticals
Chief Executive Officer
Kathi Cordova
Cyclacel Pharmaceuticals
Former Senior Vice President of Finance and Treasurer
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020